Saturday, November 8, 2008

AZOR(TM) Receives FDA Approval For Treatment Of High Blood Pressure Part 4




Impaired Renal Function In study of ACE inhibitors encircled with patients beside unilateral or bilateral renal artery stenosis, advance in serum creatinine or blood urea nitrogen (BUN) hold be gossip. There have been no long-term pay cheque out of olmesartan medoxomil in patients with unilateral or bilateral renal artery stenosis, but compatible grades may be looked-for.



Adverse Events The debt rates in the red to adverse trial (AEs) be similar with Benicar to placebo: (2.4% vs 2.7%). The rate of duplication of AEs with Benicar be akin to placebo. The lone AE that occur in >1% of patients treat with BENICAR and more repetitively than placebo was giddiness (3% vs 1%).



Dosing and Administration No gap dosage adjustment be recommended with Benicar in elderly or in lovely to well-defined renal impairment*/hepatic dysfunction. In patients with would-be depletion of intravascular hullabaloo (e.g., patients on pinnacle of diuretics, excitingly with impair renal function), Benicar should be initiate underneath out of wound`s way medical overseeing and anticipation given to use of a deprecate starting dose About Daiichi Sankyo, Inc.



Daiichi Sankyo, Inc., headquartered in Parsippany, New Jersey, be the U.S. subsidiary of Daiichi Sankyo Co., Ltd., Japan's second largest pharmaceutical amalgamated activity and a intercontinental sovereign in pharmaceutical freshness since 1899. The company is unswerving to the revealing, development and commercialization of ahead of its juncture medicine that sort out the in concert of patients all for the period of the world.



The earliest focus of Daiichi Sankyo's research and development is cardiovascular malady, plus therapy for dyslipidemia, hypertension, diabetes, and acute coronary syndrome. The company is also hunt the discovery of latest medicines in the stretch of glucose metabolic disorder, contagious disease, cancer, profession designation and joint diseases, and immune disorders.



For more talent, keep happy gawp in Please see accompanying meticulous prescribe information for AZOR and Benicar References (1) -- Last access October 12, 2006 (2) Data are representing May 2002 - February 2006 from IMS Health. National Prescription Audit, February 2006 (3) American Heart Association. 2004 High Blood Pressure Statistics ?identifier=4621 Site accessed 8/1/2007 (4) Data are representing May 2002 - February 2006 from IMS Health. National Prescription Audit, February 2006 (5) National Heart, Lung and Blood Institute, High Blood Pressure Key Points. Accessed August 1, 2007 (6) American Heart Association. 2004 High Blood Pressure Statistics. ?identifier=4621. Accessed August 1, 2007 (7) Chobanian AV, Bakris GL, Black HR et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JAMA.



2003;289:2560-2572 (8) American Heart Association. 2004 High Blood Pressure Statistics ?identifier=4621 Site accessed 8/1/2007 (9) Kearney PM, et al. Global impede of hypertension: analysis of mutual society facts. Lancet 2005, 365:217-23 Daiichi Sankyo, Inc.



cholesterol - read about



No comments: